Status:
RECRUITING
Faecal Microbiota Transplantation as Means of Preventing Recurrent Urinary Tract Infections
Lead Sponsor:
Helsinki University Central Hospital
Collaborating Sponsors:
University of Helsinki
Conditions:
Recurrent Urinary Tract Infection
Eligibility:
FEMALE
18-90 years
Phase:
PHASE2
PHASE3
Brief Summary
This study investigates Faecal microbiota transplantation (FMT) in prevention of recurrent urinary tract infections (UTIs) caused either by sensitive E. coli or ESBL-E. coli.
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Female subjects aged ≥18
- History of recurrent UTI: at least two episodes of UTI over the past 6 months or at least three episodes over the past year, most recent episode within the past three months
- Written informed consent
- Exclusion criteria:
- Suspected non-compliance
- Diagnosis of a gastrointestinal disease
- Pregnancy
- Immunosuppression
- Any kind of permanent urinary catheter or intermittent urinary catheterization
- Any other criteria which, in the investigator's opinion, would compromise the ability of the subject to participate in the study, the subject's well-being, or the outcome of the study
Exclusion
Key Trial Info
Start Date :
August 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2029
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06050148
Start Date
August 1 2023
End Date
December 31 2029
Last Update
September 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Meilahti Vaccine Research Center, Helsinki University Central Hospital
Helsinki, Finland, 00290